587 Nivolumab increased vaccine induced T-cell infiltration in Prostate cancer
Main Authors: | James L Gulley, Ravi Madan, Jennifer Marte, Fatima Karzai, Amy Hankin, Houssein Abdul Sater, Manuk Manukyan, William Dahut, Shania Bailey, Wiem Lassoued, Michell Manu, Peter Pinto, Daniel Burnett, Kenneth Canubas, Nikki William |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
-
420 PROSTVAC in combination with nivolumab enhanced immune cell infiltration in prostate cancer
by: Ravi Madan, et al.
Published: (2021-11-01) -
913 Tumor immune micro-environment (TIME) Atlas for prostate cancer bone metastasis
by: James L Gulley, et al.
Published: (2023-11-01) -
Efficacy, safety, and biomarker analyses of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with advanced non-small cell lung cancer
by: Arun Rajan, et al.
Published: (2024-03-01) -
Induction of HCA587-specific antitumor immunity with HCA587 protein formulated with CpG and ISCOM in mice.
by: Juanjuan Chen, et al.
Published: (2012-01-01) -
P587: Leveraging extensive datasets to better classify SMARCA4 variants*
by: Leora Witkowski, et al.
Published: (2023-01-01)